Related Experiment Video
Updated: Apr 13, 2026

09:40
Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
10.9K
p38 MAPK reins in right ventricular growth
The Journal of Clinical Investigation
|September 1, 2020
Summary
Researchers discovered a molecular pathway controlling right ventricle growth after birth. The p38 MAPK/IRE1α/XBP1 signaling axis specifically regulates right ventricle development by inhibiting cell cycle genes.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Developmental Biology
Background:
- The fetal heart's right ventricle (RV) supports systemic circulation, but transitions to pulmonary circulation post-birth.
- The left ventricle (LV) assumes systemic function, leading to disproportionate LV growth compared to the RV.
- The molecular mechanisms driving this differential chamber growth remain largely unelucidated.
Purpose of the Study:
- To investigate the molecular basis for differential postnatal growth between the right and left ventricles.
- To identify key signaling pathways regulating right ventricle development and size.
Main Methods:
- Utilized molecular biology techniques to study gene expression and signaling pathways in cardiac ventricles.
- Focused on the p38 mitogen-activated protein kinase (MAPK) pathway and its downstream effectors.
- Investigated the role of IRE1α and XBP1 in regulating cell cycle genes within the RV.
Main Results:
- Identified the p38 MAPK/IRE1α/XBP1 signaling axis as a critical regulator of postnatal RV growth.
- Demonstrated that this pathway specifically suppresses cell cycle regulatory genes in the RV.
- Showcased differential regulation of cardiac growth pathways between the RV and LV.
Conclusions:
- The p38 MAPK/IRE1α/XBP1 axis plays a crucial role in controlling postnatal right ventricle size.
- Understanding this pathway provides insights into the molecular basis of cardiac chamber development.
- This discovery opens avenues for investigating cardiac growth disorders.

